4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002880
Options or other derivatives
- See Remarks acquired 140,890 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dunn Judith See Remarks | 2022-01-19 | Grant or award · Stock Option (right to buy) | +140,890 | 140,890 | D | ||
Loading xslF345X03/doc4.xml…